Latino american experience with Sacubitril/Valsartan in a heart failure unit : Real insight

25 May 2019 (00:00 - 00:00)

Organised by:

Sign in to view the resources

About the speaker

Ms Astrid Rodriguez

Fundacion Santa Fe de Bogota, Bogota (Colombia)

42 More presentations in this session

Presentation thumbnail

Endomyocardial injections of autologous mesenchymal stem cell for treatment the patients with non-ischemic cardiomyopathy

Professor A. Kurlianskaya (Minsk, BY)

Presentation thumbnail

Altered number of apoptotic-modified endothelial cells originated micro vesicles predict phenotypes of heart failure

Professor A. Berezin (Salzburg, AT)

Abstract Slides

Presentation thumbnail

The plastics of atrioventricular valve in patients with chronic heart failure and severe left ventricular dysfunction

Doctor O. Shatova (Minsk, BY)

Presentation thumbnail

Population pharmacokinetics and pharmacodynamics of vericiguat in heart failure patients with reduced ejection fraction

Doctor M. Meyer (Wuppertal, DE)

Abstract Slides

Presentation thumbnail

Slow and steady wins the race- the managment of tachycardia induced cardiomyopathy

Ms C. Farrell (Letterkenny, IE)

Abstract Slides

Access the full session

Session thumbnail

Poster Session 3 - Chronic Heart Failure – Pathophysiology and Mechanisms

The Event

Heart Failure 2019

25 May - 28 May 2019

You may be interested in

Congress Presentation

Distinguishing heart failure with reduced ejection fraction from heart failure with preserved ejection fraction: a phenomics approach.

Congress Presentation

Clinical characteristics and long-term prognosis of patients with heart failure with reduced, mildly reduced, and preserved left ventricular ejection fraction secondary to Chagas cardiomyopathy

Webinar

Advanced heart failure therapy in HF patients with preserved and mildly reduced ejection fraction

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources